CAS Number3778-73-2
SynonymsP-(2-AMINOPROPYL)PHENOL; 1-p-Hydroxyphenyl-2-propylamine; 2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide; (±)-Hydroxyamphetamine; rac-iphosphamide; N,3-bis(2-chloroéthyl)-1,3,2-oxazaphosphinan-2-amine-2-oxyde; MFCD00057374; ISOPHOSPHAMIDE; Ifex (N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine-2-oxide; 2-Amino-1-(p-hydroxyphenyl)propane; 4-(2-aminopropyl)phenol; Norpholedrine; Ifosfamide; 3-(2-chloroethyl)-2-[(2-chloroethyl)-amino]-2-oxo-1,3,2-oxazaphosphorinane; Holoxan; ilfosfamide; 1-(4-hydroxyphenyl)-2-amino-propane; iphosphamide; IFEX; N,3-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide; p-Hydroxyamphetamine; Dl-p-(2-aminopropyl)phenol; (+)-4-hydroxyamphetamine; Hydroxyamphetamin; ifosphamide; 3-(2-Chloroethyl)-2-[(2-chloroethyl)
Molecular FormulaC7H15Cl2N2O2P
Molecular Weight261.09
Purity≥98%
Density1.3±0.1 g/cm3
Boiling Point336.1±52.0 °C at 760 mmHg
Melting Point48ºC
Appearancecrystalline solid
EINECS223-237-3
Symbol
Signal WordWarning
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 3778-73-2 |
| Catalog No. | 2A-9010901 |
| Chinese Name | 异环磷酰胺 |
| Synonyms | P-(2-AMINOPROPYL)PHENOL; 1-p-Hydroxyphenyl-2-propylamine; 2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide; (±)-Hydroxyamphetamine; rac-iphosphamide; N,3-bis(2-chloroéthyl)-1,3,2-oxazaphosphinan-2-amine-2-oxyde; MFCD00057374; ISOPHOSPHAMIDE; Ifex (N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine-2-oxide; 2-Amino-1-(p-hydroxyphenyl)propane; 4-(2-aminopropyl)phenol; Norpholedrine; Ifosfamide; 3-(2-chloroethyl)-2-[(2-chloroethyl)-amino]-2-oxo-1,3,2-oxazaphosphorinane; Holoxan; ilfosfamide; 1-(4-hydroxyphenyl)-2-amino-propane; iphosphamide; IFEX; N,3-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide; p-Hydroxyamphetamine; Dl-p-(2-aminopropyl)phenol; (+)-4-hydroxyamphetamine; Hydroxyamphetamin; ifosphamide; 3-(2-Chloroethyl)-2-[(2-chloroethyl) |
| Molecular Formula | C7H15Cl2N2O2P |
| Molecular Weight | 261.09 |
| Purity | ≥98 |
| Density | 1.3±0.1 g/cm3 |
| Boiling Point | 336.1±52.0 °C at 760 mmHg |
| Melting Point | 48ºC |
| Appearance | crystalline solid |
| Water Solubility | Water solubility: soluble; easily soluble in: etha |
| Storage Condition | 2-8°C |
| Packaging | III |
| Application | Ifosfamide is an alkylating agent (DNA alkylator) with broad-spectrum anti-tumor effects. |
| EINECS | 223-237-3 |
| HTC | 2934999090 |
| PubChem ID | 329815378 |
| MDL Number | MFCD00057374 |
| SMILES | ClCCNP1(=O)OCCCN1CCCl |
| InChI | 1S/C7H15Cl2N2O2P/c8-2-4-10-14(12)11(6-3-9)5-1-7-13-14/h1-7H2,(H,10,12) |
| InChI Key | HOMGKSMUEGBAAB-UHFFFAOYSA-N |
| NACRES Code | NA.25 |
| UNSPSC | 41116107 |
| Hazard Symbols | 6.1(b) |
| MSDS | msds/10901_1_3778_73_2.pdf |
| Bioactivity | Ifosfamide is an alkylating chemotherapeutic agent with activity against a wide range of tumors. Related Catalog Signaling Pathways >> Cell Cycle/DNA Damage >> DNA Alkylator/Crosslinker Research Areas >> Cancer Target DNA Alkylator[1] In Vitro Ifosfamide is an alkylating chemotherapeutic agent with activity against a wide range of tumors[1]. Ifosfamide is activated by the cytochrome P450 family. Ifosfamide (0-5 mM) suppresses the viability of CYP2B1-expressing C8III-1 cells, while it is cytotoxic to the non-CYP2B1-expressing CrFK cells only at high concentration (5 mM)[2]. CYP BM3 mutants activates Ifosfamide, and Ifosfamide shows inhibitory activity against human U2OS cells[3]. In Vivo Ifosfamide (50 mg/kg, i.p.) treatment before mating increases percentage of post-implantation loss and resorbs fetuses in pregnant rats. Ifosfamide also (50 mg/kg, i.p.) decreases the progesterone in the serum of pregnant rats. However, Ifosfamide causes no obvious difference with the control rats at 25 mg/kg. Ifosfamide (25, 50 mg/kg, i.p.) induces apoptosis and histological changes in the placentas and prenatal rats, most sensitive fetal organs are the brain, liver and kidney[1]. Cell Assay In a 3-cm dish, 4 × 104 cells are seeded in 2 mL of medium. The next day, Ifosfamide is added to final concentrations from 0 to 5 mM. After six additional days the medium is removed, the cells washed with PBS, and either stained or counted[2]. Animal Admin Rats[1] Prior to mating, female rats are divided into four groups of eight: group 1, untreated negative controls; group 2, rats injected i.p. with 1 mL 0.9% NaCl; group 3, rats injected i.p. with 25 mg/kg Ifosfamide; group 4, rats injected i.p. with 50 mg/kg Ifosfamide. After injection of Ifosfamide once daily for 5 consecutive days, three females are placed in a cage with one untreated male for up to 1 week. Vaginal smears are examined daily to determine pregnancy. The first 24 h period following mating is designated day one of pregnancy if sperm are detected. The pregnant females are housed singly and observed daily for signs of toxicity and abortion. All pregnant animals are sacrificed by decapitation on day 18 of gestation. Cardiac blood (2.5 -3 mL/rat) is collected in nonheparinized test tubes, centrifuged at 3,000× g for 30 min and the serum is decanted and stored at -70°C until used for hormone assay. After blood collection, uteri and both ovaries are removed, washed in saline solution and the corpora lutea of pregnancy are counted visually, and the number of implantation sites, resorption sites and viable fetuses are counted in each uterine horn. Each fetus is removed from its umbilical cord, weighed and the crown rump (CR) length is measured. Fetuses are examined for external malformation and the placental weights are recorded. Fetuses and placentas of control and treated groups are fixed in 10% neutral buffered formalin for immunohistochemical and histological examination[1]. References [1]. Helal M. Prenatal effects of transplacental exposure to ifosfamide in rats. Biotech Histochem. 2016 Jul;91(5):357-68. [2]. Karle P, et al. Necrotic, rather than apoptotic, cell death caused by cytochrome P450-activated ifosfamide. Cancer Gene Ther. 2001 Mar;8(3):220-30. [3]. Vredenburg G, et al. Activation of the anticancer drugs cyclophosphamide and ifosfamide by cytochrome P450 BM3 mutants. Toxicol Lett. 2015 Jan 5;232(1):182-92. Chemical & Physical Properties Density 1.3±0.1 g/cm3 Boiling Point 336.1±52.0 °C at 760 mmHg Melting Point 48ºC Molecular Formula C7H15Cl2N2O2P Molecular Weight 261.086 Flash Point 157.1±30.7 °C Exact Mass 260.024811 PSA 51.38000 LogP 0.23 Vapour Pressure 0.0±0.7 mmHg at 25°C Index of Refraction 1.506 InChIKey HOMGKSMUEGBAAB-UHFFFAOYSA-N SMILES O=P1(NCCCl)OCCCN1CCCl Storage condition 2-8°C |
| Use of | Ifosfamide is an alkylating chemotherapeutic agent with activity against a wide range of tumors. Properties Articles92 Name ifosfamide Synonym More Synonyms Ifosfamide Biological Activity Description Ifosfamide is an alkylating chemotherapeutic agent with activity against a wide range of tumors. Related Catalog Signaling Pathways >> Cell Cycle/DNA Damage >> DNA Alkylator/Crosslinker Research Areas >> Cancer DNA Alkylator[1] References [1]. Helal M. Prenatal effects of transplacental exposure to ifosfamide in rats. Biotech Histochem. 2016 Jul;91(5):357-68. [2]. Karle P, et al. Necrotic, rather than apoptotic, cell death caused by cytochrome P450-activated ifosfamide. Cancer Gene Ther. 2001 Mar;8(3):220-30. Chemical & Physical Properties Exact Mass 260.024811 PSA 51.38000 Index of Refraction 1.506 InChIKey HOMGKSMUEGBAAB-UHFFFAOYSA-N |
| Tax Rebate | 13.0% |
| Supervision | None. MFN tariff: 6.5%. Ordinary tariff: 20.0% |
| Transport Info | Shipping Name: UN |
| MSDS Transport Info | Module 14. Shipping information 14.1 UN dangerous goods number European Dangerous Regulations for land transport: 2811 International Dangerous Regulations for sea transport: 2811 International Dangerous Regulations for air transport: 2811 14.2 United Nations shipping name European Land Transport Dangerous Regulations: TOXIC SOLID, ORGANIC, N.O.S. (Ifosfamide) IMDG: TOXIC SOLID, ORGANIC, N.O.S. (Ifosfamide) International air transport hazard regulations: Toxic solid, organic, n.o.s. (Ifosfamide) 14.3 Transport hazard categories European Land Transport Danger Regulations: 6.1 International Maritime Transport Danger Regulations: 6.1 International Air Transport Danger Regulations: 6.1 14.4 Package group European Land Transport Danger Regulations: III International Maritime Transport Danger Regulations: III International Air Transport Danger Regulations: III 14.5 Environmental hazards European Land Transport Danger Regulations: No International Maritime Danger Regulations International Air Transport Danger Regulations: No Marine pollutants (yes/no): No 14.6 Special reminder to users No data available |
| Related Products in API & Advanced Intermediates | ||
|---|---|---|
| Ibandronate sodium | 138926-19-9 | 2A-9010881 |
| IBUPROFEN USP | 15687-27-1 | 2A-0202344 |
| Idarubicin | 58957-92-9 | 2A-9010888 |
| Idarubicin Hydrochloride | 57852-57-0 | 2A-9010889 |
| Idarubicinol | 86189-66-4 | 2A-9010890 |
| Imatinib mesylate | 220127-57-1 | 2A-9010911 |
| Imipenem | 64221-86-9 | 2A-9010926 |
| Imipenem and Cilastatin Sodium | 85960-17-4 | 2A-9010927 |
| Imipramine N-oxide | 6829-98-7 | 2A-9010928 |
| Indinavir | 157810-81-6 | 2A-9010941 |
| Browse all API & Advanced Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS